GMP in Pharmaceutical Industry: Principles, Requirements & Real Examples

Published by: Pharma Quality System Editorial Team • Editorial basis: FDA 21 CFR Parts 210 and 211, Health Canada GUI-0001, WHO GMP, and ICH Q10 • Last reviewed: September 4, 2026

GMP in pharmaceutical industry good manufacturing practice in a pharmaceutical production facility

Good Manufacturing Practice (GMP) is one of the foundations of pharmaceutical quality. It is the system used to make sure medicines are consistently produced and controlled according to defined quality standards-not only tested at the end of manufacturing.

For anyone entering pharmaceutical Quality Assurance (QA), Quality Control (QC), production, validation, regulatory affairs, or engineering, understanding GMP is essential. GMP influences how materials are received, how equipment is used, how records are completed, how deviations are investigated, how products are tested, and how a batch is released.

Quick answer: GMP stands for Good Manufacturing Practice. It is a quality system designed to ensure pharmaceutical products are consistently manufactured and controlled to standards appropriate for their intended use.

PQS Virtual Pharmaceutical Facility QA Manufacturing Walkthrough

Walk the plant like a QA inspector

GMP Virtual Facility Inspection

Move through gowning, dispensing, granulation, compression, packaging and warehouse areas. Inspect real-looking conditions, collect objective evidence, write findings and decide when a batch or operation should be held for assessment.

Inside the inspection gowning control • material status • line clearance • documentation • product containment • printed-component segregation • warehouse HOLD control • QA disposition

☀ Normal Inspection ☾ Dark Inspection

Enter the GMP Facility →

Room walkthroughs • Interactive hotspots • Findings • Risk assessment • Final inspection summary

Packaging Line 03Inspection hotspot active

BLISTER
LINE RUN

LINE CLEARANCE
VERIFIED

Table of Contents

Virtual GMP Facility Inspection
What GMP Means
PQS GMP System Map
Main GMP Requirements
PQS GMP Readiness Assessment
Requirement vs Common Practice vs PQS Interpretation
Tablet Batch Example
PQS Site Walkthrough
Inspection-Style Scenario Matrix
Downloadable GMP Readiness Checklist

What Does GMP Mean in the Pharmaceutical Industry?

GMP is a structured approach to pharmaceutical manufacturing that controls the factors capable of affecting product quality. According to the World Health Organization (WHO), GMP is the part of quality assurance that ensures medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and product specifications.

GMP covers much more than the manufacturing room. It includes areas such as:

Quality management systems
Personnel training and responsibilities
Premises and equipment
Raw materials and packaging materials
Written procedures and documentation
Production and process controls
Laboratory controls and Quality Control testing
Qualification and validation
Handling deviations, investigations, CAPA, and change
Complaints, recalls, and self-inspection
Storage and distribution controls

PQS GMP System Map: How the Main Controls Connect

GMP is easier to understand when viewed as a connected control system rather than a list of departments. Each element creates evidence that supports the next quality decision.

GMP system	Control objective	Typical evidence	If weak...
People	Competent personnel perform defined responsibilities.	Training, qualification, job responsibilities.	Errors may be blamed on people without fixing the underlying system.
Premises & Equipment	Facilities and equipment remain suitable and controlled.	Qualification, calibration, maintenance, cleaning, status labels.	Contamination, mix-ups or unreliable processing can occur.
Materials	Only correctly identified and approved materials enter production.	Receipt, status, sampling, testing, approval, storage and issuance records.	Wrong or unapproved material may be used.
Process	Manufacturing remains within approved instructions and controls.	Batch records, IPCs, process parameters, line clearance.	Final testing may not reveal all process failures.
Laboratory	Testing generates reliable evidence against approved specifications.	Methods, SST, raw data, calculations, review and investigations.	A passing report may not be scientifically defensible.
Quality System	Unexpected events are evaluated and learning is converted into control.	Deviation, CAPA, change control, complaints, trends, management oversight.	Problems repeat while records accumulate.

The central idea is simple: quality must be built into the process. Finished-product testing alone cannot prove that every unit in a large batch was manufactured correctly.

GMP vs cGMP: What Is the Difference?

You will often see both GMP and cGMP. In the United States, the FDA commonly uses the term CGMP, meaning Current Good Manufacturing Practice.

The word current emphasizes that manufacturers are expected to use up-to-date systems, controls, technologies, and practices. In everyday pharmaceutical work, GMP and cGMP are often used to describe the same overall objective: maintaining a controlled manufacturing system that consistently produces medicines of the required quality.

Why Is GMP Important in Pharmaceuticals?

Medicines are different from ordinary consumer products because patients usually cannot determine by appearance, taste, or smell whether a product has the correct identity, strength, purity, or quality.

GMP is designed to reduce manufacturing risks that cannot be fully eliminated by testing a small sample from a finished batch. These risks can include:

Contamination or cross-contamination
Mix-ups between products or materials
Incorrect labels or packaging
Incorrect amount of active ingredient
Uncontrolled manufacturing processes
Inaccurate or incomplete records
Use of unsuitable equipment or facilities
Failure to investigate deviations properly

What Are the Main GMP Requirements?

1. Pharmaceutical Quality System

A manufacturer needs an effective system for managing pharmaceutical quality. Responsibilities must be clearly defined, quality problems must be investigated, and management must provide appropriate resources and oversight. ICH Q10 describes a model for a Pharmaceutical Quality System that complements regional GMP requirements.

2. Qualified and Trained Personnel

Employees must have suitable education, training, experience, and clearly defined responsibilities. GMP training should be relevant to the procedures and activities each person performs.

3. Suitable Premises and Equipment

Facilities and equipment must be designed, located, maintained, and operated in a way that reduces contamination, errors, and mix-ups. Controls may include cleaning, environmental controls, preventive maintenance, calibration, qualification, and access control.

4. Control of Raw Materials and Packaging Materials

Materials are managed through controlled receipt, identification, quarantine, sampling, testing or appropriate verification, approval, storage, and issuance.

5. Documentation and Record Control

Documentation demonstrates what was done, when it was done, how it was done, and who performed or reviewed the activity.

Standard Operating Procedures (SOPs)
Specifications
Batch manufacturing and packaging records
Laboratory records
Equipment logs
Training records
Deviation and investigation reports
CAPA records
Change control records
Validation and qualification records

6. Controlled Manufacturing Processes

Production should follow approved written instructions. Critical steps and process parameters should be controlled, and unexpected events should be assessed according to established procedures.

7. Quality Control and Laboratory Controls

GMP includes Quality Control. QC laboratories test materials and products against approved specifications using suitable methods and controlled laboratory systems.

Typical pharmaceutical QC activities may include identification, assay, related substances, dissolution, uniformity, moisture testing, microbiological testing where applicable, and stability testing.

For a deeper comparison between QA and QC, read our guide: Quality Assurance vs Quality Control in the Pharmaceutical Industry.

8. Qualification and Validation

Pharmaceutical companies need documented evidence that critical facilities, utilities, equipment, processes, cleaning procedures, computerized systems, and analytical procedures are suitable for their intended purpose when qualification or validation is required.

9. Deviations, Investigations, CAPA, and Change Control

A deviation should be documented and assessed. Significant problems may require investigation to determine the root cause. Corrective and Preventive Actions (CAPA) may then be established to correct the problem and reduce the likelihood of recurrence.

10. Complaints, Recalls, and Self-Inspection

Companies need systems for evaluating product complaints and quality defects and for taking appropriate action when a product may need to be recalled. Internal audits help identify weaknesses before they develop into serious compliance problems.

PQS GMP Readiness Assessment: Ten Questions Before an Inspection

Quality system: Can recurring issues be identified from deviations, complaints, CAPA and trends?
Personnel: Can operators explain the current procedure they actually perform?
Facilities/equipment: Is status obvious, and are maintenance, cleaning, calibration and qualification records current where required?
Materials: Can each material's identity, status, storage and movement be traced?
Documentation: Do records show what actually happened, without unexplained blanks, backdating or reconstructed entries?
Production: Are critical steps, parameters, line clearance and in-process controls documented in real time?
Laboratory: Can the complete data behind a reported result be reconstructed and reviewed?
Validation: Is there evidence that critical processes, systems and methods are suitable for intended use?
Investigations/change: Are deviations investigated with evidence, and are planned changes assessed before implementation?
Release/oversight: Does the batch disposition decision consider manufacturing, laboratory and quality-system evidence together?

PQS readiness rule:
A site is not inspection-ready because the SOP exists. It is ready when the current procedure, actual practice, records and supporting evidence all agree.

Regulatory Requirement vs Common Industry Practice vs PQS Interpretation

Topic	Regulatory framework	Common industry practice	PQS interpretation
Training	Personnel should be appropriately qualified/trained for assigned functions.	Read-and-understand plus practical qualification for selected tasks.	A training signature alone does not prove the person can perform the task correctly.
Equipment status	Equipment must be suitable, maintained and controlled.	Status labels, electronic status, logbooks and maintenance schedules.	The operator should be able to tell immediately whether equipment is fit for use.
Documentation	Activities and controls must be documented as required.	Controlled forms, batch records, logbooks and electronic systems.	The record should reconstruct reality, not merely look complete.
Deviation/CAPA	Significant discrepancies should be investigated and appropriate corrective action taken.	Risk classification, root-cause tools, CAPA plans and effectiveness checks.	Closing records quickly is not the same as restoring control.
Batch release	Disposition must be based on appropriate review of manufacturing and testing records.	QA/QC release workflow with checklist and review of open quality events.	Passing QC results cannot compensate for unresolved manufacturing evidence.

The “5 Ps of GMP”: Useful Memory Tool, Not the Whole Regulation

People
Premises
Processes
Products
Procedures

This can be a useful learning tool, but it should not be treated as a complete regulatory checklist. Actual GMP requirements are more detailed and depend on the applicable regulatory framework and product type.

Real GMP Example: Manufacturing a Tablet Batch

Consider a company manufacturing a batch of tablets. GMP controls appear throughout the process-not only when QC tests the final tablets.

Step 1: Raw Material Receipt

The active pharmaceutical ingredient and excipients are received, identified, assigned status, stored under defined conditions, sampled according to procedure, and approved before use.

Step 2: Dispensing

Approved materials are weighed according to authorized manufacturing instructions. Material identity, quantity, equipment status, and line clearance are checked and documented.

Step 3: Manufacturing

The batch proceeds through required operations while critical process parameters and in-process results are recorded.

Step 4: In-Process Controls

Depending on the process, parameters such as tablet weight, hardness, thickness, appearance, or other approved in-process controls may be monitored.

Step 5: Finished-Product Testing

QC performs the required tests according to approved methods and specifications. Results are documented and reviewed.

Step 6: Batch Review and Release

Passing laboratory results alone do not automatically mean the batch can be released. The appropriate quality function reviews manufacturing and testing records, deviations, investigations, and other relevant information before disposition.

PQS Practical GMP Site Walkthrough: What Would You Look For?

Area	Look for	Ask for evidence	Red flag
Warehouse	Clear status, segregation, labels, storage conditions.	Receipt, sampling, release/rejection and temperature records.	Approved and quarantined materials can be confused.
Dispensing	Line clearance, material identity, balance status, controlled labels.	Weighing record, equipment log, reconciliation.	Material identity or quantity cannot be independently reconstructed.
Production	Current instruction, equipment status, real-time entries, controlled parameters.	Batch record, IPC results, deviations, cleaning logs.	Operator practice differs from the approved batch instruction.
QC laboratory	Controlled methods, standards, complete data and appropriate review.	Raw data, calculations, audit trails/metadata as applicable, investigations.	Only the final passing report is available.
QA / Release	Integrated review of manufacturing, testing and quality events.	Batch disposition record, deviation/CAPA/change status, review evidence.	Release is treated as a signature after QC passes.

Who Regulates GMP in the Pharmaceutical Industry?

U.S. FDA

For finished pharmaceutical drugs in the United States, FDA CGMP requirements are principally found in 21 CFR Parts 210 and 211.

Health Canada

Health Canada

In Canada, pharmaceutical GMP requirements are established primarily under Part C, Division 2 of the Food and Drug Regulations. Health Canada's GUI-0001 provides guidance on how these GMP requirements are interpreted and applied during regulated drug activities and inspections.

World Health Organization (WHO)

WHO publishes GMP standards and guidance used internationally.

European Union

EudraLex Volume 4 contains EU GMP guidance for medicinal products.

ICH

The International Council for Harmonisation publishes quality guidelines relevant to pharmaceutical manufacturing, including ICH Q7 and ICH Q10.

Common GMP Mistakes in Pharmaceutical Companies

Not following an approved SOP
Incomplete or inaccurate documentation
Poor investigation of deviations or laboratory failures
Inadequate cleaning or contamination controls
Insufficient employee training
Using equipment outside its approved or calibrated status
Weak material status control
Unauthorized changes to processes or methods
Failure to review recurring quality trends
Weak CAPA effectiveness checks

PQS Inspection-Style GMP Scenario Matrix

These are illustrative training scenarios. They show how an apparently small observation can reveal a broader control-system question.

Observation	Immediate concern	Follow-up evidence
Operator is following a printed SOP with an old revision.	Document control / training / implementation failure.	Distribution list, withdrawal record, effective date, training and impact on executed batches.
Equipment shows “calibrated” status, but the current certificate cannot be located.	Status may not be supported by objective evidence.	Calibration record, due date, maintenance history, use since last verified status.
Three similar deviations were closed as “operator error.”	Weak root-cause analysis and trending.	Training design, procedure usability, workload, equipment, supervision, trend review and CAPA effectiveness.
QC result passes, but the batch record has an unresolved critical process deviation.	Batch disposition may not be scientifically supportable yet.	Deviation investigation, product impact, process data, validation knowledge and QA disposition rationale.
Warehouse labels are clear, but rejected material is physically stored with approved material without adequate segregation/control.	Material status system may rely on labels alone.	Physical/electronic segregation, access controls, movement records and reconciliation.

Downloadable GMP Readiness Checklist

Download: PQS GMP Readiness Checklist

A practical five-page site self-assessment covering quality systems, personnel, premises/equipment, materials, documentation, manufacturing, laboratory controls, validation, investigations, release and action planning.

Open the PDF checklist

GMP vs QA vs QC

Term	Main Focus	Simple Example
GMP	Regulated manufacturing and quality controls	Approved procedures, controlled facilities, documented manufacturing and testing
QA	Overall assurance that the quality system is established and functioning	Batch review, deviations, CAPA, change control, audits
QC	Testing and evaluation against specifications	HPLC assay, dissolution, identification, stability testing

Why GMP Knowledge Matters for Pharma Careers

Entry-level candidates applying for QA, QC, production, validation, microbiology, warehousing, or regulatory functions are frequently expected to understand GMP concepts.

What GMP and cGMP mean
Why documentation is important
What an SOP is
What a deviation is
What CAPA means
Why calibration and validation matter
The difference between QA and QC
Why data integrity matters

Frequently Asked Questions About GMP

What is GMP in pharmaceuticals?

GMP stands for Good Manufacturing Practice. It is the system used to ensure pharmaceutical products are consistently manufactured and controlled according to defined quality standards.

What does cGMP stand for?

cGMP stands for Current Good Manufacturing Practice. The term is commonly used by the U.S. FDA to emphasize the use of current systems and practices.

Is GMP the same as Quality Control?

No. Quality Control is one part of the broader pharmaceutical quality system. GMP covers manufacturing, documentation, personnel, facilities, equipment, materials, testing, and many other controls.

Can final-product testing replace GMP?

No. Quality must be built into the manufacturing process because final testing cannot eliminate every manufacturing risk.

What are 21 CFR Parts 210 and 211?

They are key U.S. FDA regulations containing current good manufacturing practice requirements for manufacturing, processing, packing, or holding drugs, including requirements for finished pharmaceuticals.

Final Takeaway

GMP is the foundation that turns pharmaceutical quality from an intention into a controlled, documented, and reviewable system. It requires manufacturers to control people, materials, equipment, facilities, processes, testing, and records so that medicines are consistently produced to the required standards.

Editorial note: Pharma Quality System distinguishes regulatory requirements and official guidance from simplified educational examples and common industry practice. Learn more about our review process in the Pharma Quality System Editorial Team page.